Digital transformation continues to play out across various corners of the healthcare world, and the cardiovascular space is no different. Heart disease remains one of the deadliest and costliest ...
The planned acquisition of V-Wave will extend Johnson & Johnson MedTech's position in addressing cardiovascular disease. The FDA also approved Rybrevant (amivantamab) plus Lazcluze (lazertinib) for ...
The 2025 Lubbock Heart Walk, the signature event of the American Heart Association, will return to the Texas Tech campus on ...
New research highlights the impact of workplace stress on heart health and underscores the need for wellness interventions. Study: Work‐Related Stress Is Associated With Unfavorable Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback